Arcus Biosciences, Inc. — Director's Dealing 2021

Jan 20, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcus Biosciences, Inc. (RCUS)
CIK: 0001724521
Period of Report: 2021-01-19

Reporting Person: Jarrett Jennifer (Director, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-19	Common Stock	A	400000	$0.00	Acquired	500634	Direct

Footnotes

F1: Represents the grant of restricted stock units that vest in quarterly installments after January 1, 2021, subject to the Reporting Person's continued service to the Company.